In a study carried out between 2024 and 2025, shared in the Euro Surveillance journal, scientists examined the persistence of Monkeypox virus (MPXV) in high-consequence infectious disease centers in the United Kingdom. This study emerged following the identification of eight patients exhibiting MPXV infection symptoms during this period.
The patients, who were admitted to these centers…